Dendritic Cell Culture: A Simple Closed Culture System Using Ficoll, Monocytes, and a Table-Top Centrifuge
Authors:
- Christina M. CelluzziCCChristina M. Celluzzi
- Craig WelbonCWCraig Welbon
- 1 October 2003
- journal article
- research article
- Published by SAGE Publications in Journal of Hematotherapy & Stem Cell Research
- Vol. 12 (5) , 575-585
Abstract
Dendritic cells (DCs) are potent antigen-presenting cells involved in the induction of T cell-mediated immune responses and as such have emerged as important candidates for cellular-based therapies. Critical to safe clinical use is the easy manipulation of DCs and their precursors in a closed system. We have developed a serum-free, closed culture system applying a simple wash-Ficoll centrifugation method to reduce platelet and red blood cell (RBC) contamination. This procedure optimized adherence of monocytes (44 ± 10.9% recovery, >85% expressed CD14+/CD163+) for the generation of DCs from mononuclear cell (MNC) apheresis units. Most RBCs and up to 98% of platelets were removed. Following density sedimentation, cell viability remained high (98 ± 2%) with only minimal loss of monocytes (3 ± 3%). Importantly, Ficoll-treated monocytes retained their ability to differentiate to mature DCs demonstrated by morphology, phenotype (MHC class II+, CD1a+, CD80+, CD86+, and CD83+), ability to stimulate mixed lymphocyte responses (MLR), present antigen, and produce interleukin-12 (IL-12). Nonadherent CD3+ (80 ± 4%) were also isolated for functional assays. Ficoll can be easily incorporated into a simple adherence-based closed system for collection of lymphocytes and adherent monocytes for DC culture. The procedure is relatively fast (effective working time 5–6 h), does not impair monocyte function or induce substantial cell activation, and can be performed economically using equipment found in a typical blood banking environment.Keywords
This publication has 21 references indexed in Scilit:
- Development of a closed-system process for clinical-scale generation of DCs: evaluation of two monocyte-enrichment methods and two culture containersCytotherapy, 2002
- Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapyCytotherapy, 2001
- Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin toleranceEuropean Journal of Immunology, 1998
- Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cellsNature Medicine, 1998
- Dendritic cells: Therapeutic potentialsTransfusion Science, 1997
- Improved methods for the generation of dendritic cells from nonproliferating progenitors in human bloodJournal of Immunological Methods, 1996
- Generation of mature dendritic cells from human blood An improved method with special regard to clinical applicabilityJournal of Immunological Methods, 1996
- Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.Journal of Experimental Medicine, 1996
- Generation of antigen‐specific CD4+ T cell lines from naive precursorsEuropean Journal of Immunology, 1995
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.Journal of Experimental Medicine, 1994